ClariVest Asset Management’s Altimmune ALT Stock Holding History

ClariVest Asset Management’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-37,400	Closed	-$615K	–	721
2022 Q4	$615K	Sell	37,400 -700	-2%	-$7.86K	0.03%	358
2022 Q3	$487K	Sell	38,100 -6,500	-15%	-$96K	0.02%	367
2022 Q2	$522K	Buy	+44,600	New	+$275K	0.02%	366
2017 Q2	–	Sell	-1,077	Closed	-$262K	–	658
2017 Q1	$262K	Buy	1,077 +698	+184%	+$373K	0.01%	457
2016 Q4	$369K	Buy	+379	New	+$340K	0.01%	429

Other funds holding ALT

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

ClariVest Asset Management's ALT Position: Q1 2023 in Review

ClariVest Asset Management sold out of Altimmune (ALT) in Q1 2023, closing a stake of 37,400 shares — an estimated $615K sold.

ClariVest Asset Management first reported a position in ALT in Q4 2016 and held it in 5 quarters. The position peaked at $615K in Q4 2022. 132 funds tracked by Wall St. Rank hold ALT as of Q1 2023.

ClariVest Asset Management reported no remaining Altimmune position as of Q1 2023 after selling out during the quarter.
ClariVest Asset Management sold 37,400 Altimmune shares in Q1 2023, an estimated $615K.
ClariVest Asset Management first reported a position in Altimmune in Q4 2016 and held it in 5 quarters.
ClariVest Asset Management's Altimmune position peaked at $615K in Q4 2022.
132 funds tracked by Wall St. Rank held Altimmune as of Q1 2023.

Based on ClariVest Asset Management's 13F filing for Q1 2023, filed 8 May 2023.